“Anti-Aging Medicine” Sounds Vaguely Disreputable, So Serious Scientists Prefer to Speak of “Regenerative Medicine”.

Induced pluripotent stem cells (iPSCs) and genome-editing techniques have facilitated manipulation of living organisms in innumerable ways at the cellular and genetic levels, respectively, and will underpin many aspects of regenerative medicine as it continues to evolve. An attitudinal change is also occurring. Experts in regenerative medicine have increasingly begun to embrace the view that comprehensively repairing the damage of aging is a practical and feasible goal.

Dr. Dennis Clegg recently visited NIH and gave a summary of his efforts with the California Project to Cure Blindness to develop a stem cell-based therapy for age-related macular degeneration (AMD), a major cause of blindness in the U.S. His talk was the second installment in the National Eye Institute Audacious Goals Initiative Seminar Series in Neuroregeneration.